Entrada Therapeutics Inc.

13.34
0.16 (1.21%)
At close: Jan 28, 2025, 2:31 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -74.6 -4.84 -10.68 -28.37 -160.98
PS Ratio 3.87 n/a n/a n/a n/a
PB Ratio 2.06 1.99 1.79 -18.04 -48.23
P/FCF Ratio 3.72 -4.38 -9.64 -26.83 -65.47
P/OCF Ratio 3.57 -4.51 -10.51 -29.27 -69.29
OCF/S Ratio 1.08 n/a n/a n/a n/a
Debt / Equity Ratio 0.28 0.12 n/a n/a n/a
Quick Ratio 2.33 9.55 44.46 11.89 9.08
Current Ratio 2.33 9.55 44.46 11.89 9.08
Asset Turnover 0.27 n/a n/a n/a n/a
Interest Coverage n/a -36.95 n/a n/a n/a
Return on Equity (ROE) -0.03 -0.41 -0.17 0.64 0.30
Return on Assets (ROA) -0.01 -0.35 -0.16 -0.61 -0.25
Return on Capital (ROIC) -0.01 -0.42 -0.17 -0.66 -0.72
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin 22.58% n/a n/a n/a n/a
Net Profit Margin -5.18% n/a n/a n/a n/a
Pretax Profit Margin 9.34% n/a n/a n/a n/a
Operating Profit Margin -2.45% n/a n/a n/a n/a
FCF Margin 104.01% n/a n/a n/a n/a
EBITDA Margin -0.25% n/a n/a n/a n/a